• N/A
    Market Cap
  • 4.70%
    1-Year Change
  • Medical Instruments & Supplies
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 46
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

Global Dental Equipment Market is expected to generate a revenue of USD 17.68 Billion by 2032, Globally, at 12.35% CAGR: Verified Market Research®

The global dental equipment market is projected to grow from USD 6.97 billion in 2024 to USD 17.68 billion by 2032, expanding at a CAGR of 12.35%. Growth is driven by increasing demand for digital dentistry solutions, rising prevalence of dental disorders, and advancements in imaging technologies. However, high equipment costs, regulatory challenges, and a limited skilled workforce present significant restraints to market expansion.

01/08/2026, 10:22 PMGlobeNewswire

AI-Based Caries Detection Presents a $1.11 Billion Global Market Opportunity by 2029

The AI-based caries detection market is projected to grow from $0.62 billion in 2025 to $1.11 billion by 2029 at a 15.6% CAGR, driven by rising dental disease prevalence, aging populations, and increased preventive dentistry adoption. Key innovations include VideaHealth's Caries 3 model and partnerships like Dentalcorp's integration of AI detection technology. However, U.S. tariffs and trade tensions are pressuring margins in the medical equipment sector.

01/07/2026, 12:25 PMGlobeNewswire

Peers

Statistics

More
Day Range
$12.81
$13.29
$13.07
1-Year Range
$9.45
$13.80
$13.07
Latest Close$13.07
Change
-$0.06 (-0.50%)
Volume25,623

Information as of 06/22/2026

Company Profile

Straumann Holding AG / ADR
https://www.straumann.com
N/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Medical Instruments & Supplies
Peter Merian-Weg 12, Basel, Switzerland, 4002
41 61 965 11 11

Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It operates through Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations segments. The company offers dental implants, instruments, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. It also provides implant systems, components, and related instruments, as well as healing components, materials and surfaces, surgical sets and instruments, and guided surgery and navigation products; prosthetics, including angled solutions, connections, components, and molar solutions; intra-oral and lab scanners, milling machines, dynamic navigation systems, and 3D printers; consumables, such as blocks, discs, resins, titanium bases, and abutment blanks, as well as scan bodies, analogs, and sleeves; online education; and dentists and dental labs solutions. In addition, the company offers regenerative solutions for tooth preservation, implant-site management, and implant preservation; scanner hardware, software licenses, sterile-packaged products, customer training, and other products; and logistics and supply chain services. Further, it provides thermoplastics; implant treatment referral; high-tech materials; artificial intelligence solutions for dental applications; and 3D orthodontic treatment animations. The company sells its products under the Straumann, Neodent, Medentika, Anthogyr, ClearCorrect, NUVO, and other brands through a network of distribution subsidiaries and partners, and third-party distributors, as well as through its e-shop. It serves clinicals needs, patient segments, and healthcare systems. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

Key Executives

  • Guillaume Daniellot
  • Thomas Friese
  • Sébastien Roche
  • Florian Kirsch
  • Holger Haderer

Current Ownership Distribution

  • Other1.6B (99.91%)
  • Institutions1.2M (0.08%)
  • Mutual Funds229,387 (0.01%)
  • Insiders0 (0.00%)